Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Trading Statement

2 Apr 2020 07:40

RNS Number : 5522I
Thruvision Group PLC
02 April 2020
 

2 April 2020

 

Thruvision Group plc

 

("Thruvision" or the "Group")

 

Pre-close statement

 

 

Thruvision (AIM: THRU), the specialist provider of people-screening technology to the international security market, is pleased to provide an update on trading for the financial year ended 31 March 2020.

 

The Group maintained good momentum through much of the second half of the year, with good revenue growth complemented by continued strategic progress in our profit protection and aviation markets. However, the recent COVID-19 pandemic has caused a material slowdown in order-flow in March, meaning full year revenues are now expected to be £8.0 million (FY19: £6.0 million), somewhat below our previous expectations.

 

Second half sales saw repeat orders from existing customers, including an Asian government and supermarket group, Morrisons, which is rolling out Thruvision units across its Distribution Centre estate. Two new profit protection customers ordered their first units, one of which, significantly, is our first in North America. We also received our first order for the Group's new higher performance 16-channel sensor from a global technology firm seeking to improve data centre security. We continued to support ongoing rollouts of units purchased by international Customs agencies in the first half of the year, and we made steady progress through ongoing US Transportation Security Administration laboratory testing and airport employee security trials.

 

Regarding COVID-19, with due regard to government advice, we have taken all necessary steps to look after the health and wellbeing of our staff. The pandemic has impacted the Group's trading in three ways. Firstly, a number of orders have been delayed as customers review their own trading positions. Secondly, a number of trials, both in the UK and overseas, have been postponed due to their inherent logistical challenges in the current climate. Finally, our current view is that our supply chain will allow us to sustain moderate production levels for the next three months. Accordingly, given the evolving nature of COVID-19, it is too early to provide guidance on the potential impact on the Group in the new financial year ending 31 March 2021.

 

We have implemented measures to tighten cash flow management over the coming months, even though we are in the fortunate position of having a healthy cash balance and zero debt. Cash at 31 March 2020 was £8.6 million, broadly unchanged from the position at 30 September 2019.

 

More positively, we are encouraged by the recent uptick in interest relating to Thruvision's unique ability to provide effective "hands off" security screening at a safe distance, without the need for physical "patdowns". We believe this aspect to our technology, our strong balance sheet and the strength and depth of our sales pipeline mean we are well positioned to continue to trade through this difficult period and we remain confident about our strategic prospects.

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Shamma Kelly

 

 

 

 

About Thruvision

Thruvision Group plc is a specialist provider of people-screening technology that can safely see weapons, explosives and contraband hidden in peoples' clothing. Developed with extensive support from the British and US Governments, Thruvision technology is operationally proven and is being used to enhance the security of transport hubs, borders, high profile buildings and public areas.

 

 

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFZGGDVZNGGZG
Date   Source Headline
31st May 20245:06 pmRNSHolding(s) in Company
30th May 20247:00 amRNSThruvision partners with Sensormatic Solutions
22nd May 202412:26 pmRNSBlock listing Interim Review
22nd May 202412:26 pmRNSBlock listing Interim Review
26th Apr 20247:00 amRNSYear-end trading update
18th Mar 20247:00 amRNSWalkTHRU completes operational test and evaluation
1st Feb 20247:00 amRNSNext generation product range & software launched
26th Jan 20247:00 amRNSSales Progress Update
22nd Jan 20242:48 pmRNSHolding(s) in Company
10th Jan 202410:39 amRNSAward of Share Options to Executive Director
28th Nov 202311:50 amRNSBlocklisting update
28th Nov 202311:48 amRNSBlocklisting update
20th Nov 20237:00 amRNSInterim Results
13th Nov 20238:51 amRNSUK retail theft to cost £7.9bn in 2023
6th Nov 20234:27 pmRNSNotice of Interim Results
27th Oct 202311:32 amRNSHolding(s) in Company
26th Oct 20232:34 pmRNSHolding(s) in Company
26th Oct 20232:23 pmRNSHolding(s) in Company
25th Oct 202312:04 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSResult of placing
23rd Oct 20234:35 pmRNSLaunch of placing
2nd Oct 20237:00 amRNSHalf year trading update
21st Sep 202311:12 amRNSResult of Annual General Meeting
22nd Aug 202311:56 amRNSAward of Share Options to Executive Directors
21st Jul 20237:00 amRNSResults for the year ended 31 March 2023
13th Jul 20235:09 pmRNSNotice of Results
7th Jun 20237:00 amRNSBlocklisting update
7th Jun 20237:00 amRNSBlocklisting update
21st Apr 20237:00 amRNSYear end trading update
3rd Feb 20237:00 amRNSSharesave option grant to Executive Director
12th Jan 202310:24 amRNSChange of Auditor
21st Dec 20227:00 amRNSDirector Share Dealing
19th Dec 20227:00 amRNSInterim Results
15th Dec 20227:00 amRNSCORRECTION - Blocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
30th Nov 20227:00 amRNSNotice of Results
9th Nov 20227:00 amRNSAward of Share Options to Executive Directors
8th Nov 20222:50 pmRNSHolding(s) in Company
26th Oct 202211:50 amRNSResult of AGM
12th Oct 20227:00 amRNSH1 Trading Update
3rd Oct 20227:00 amRNSCBP Framework Agreement and Contract Award
30th Sep 20227:00 amRNSResults for the Year ended 31 March 2022
22nd Sep 20223:00 pmRNSContract Award, Trading Update, Notice of Results
16th Jun 20227:00 amRNSAppointment of Chief Financial Officer
15th Jun 20228:31 amRNSHolding(s) in Company
8th Jun 20223:32 pmRNSBlocklisting update
8th Jun 20223:30 pmRNSBlocklisting update
6th May 202212:12 pmRNSDirector Share Dealing-correction & further trade
20th Apr 20227:00 amRNSDirector Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.